486 related articles for article (PubMed ID: 18998259)
1. Clinical investigations in aggressive non-Hodgkin lymphoma.
Jonathan F
Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
[No Abstract] [Full Text] [Related]
2. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
Cheson BD
Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
[No Abstract] [Full Text] [Related]
3. New concepts in treatment approaches and prognostic factors in aggressive NHL.
Shipp M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
[No Abstract] [Full Text] [Related]
4. [Treatment of lymphoma in the aged].
Gómez H; Colomer R
Med Clin (Barc); 1998 May; 110(15):574-5. PubMed ID: 9650201
[No Abstract] [Full Text] [Related]
5. Complete regression of cardiac non-Hodgkin lymphoma.
Morillas P; Quiles J; Nuñez D; Senent C; Martínez S; Fernández JA; Bertomeu V
Int J Cardiol; 2006 Jan; 106(3):426-7. PubMed ID: 16337063
[No Abstract] [Full Text] [Related]
6. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
Korolenko VO; Gershanovich ML; Tikhonova VV
Vopr Onkol; 2004; 50(4):421-5. PubMed ID: 15605764
[No Abstract] [Full Text] [Related]
7. Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
Chakravarti A; Leslie WT; Venugopal P
Clin Adv Hematol Oncol; 2005 Feb; 3(2):136-9; discussion 139-40. PubMed ID: 16166983
[No Abstract] [Full Text] [Related]
8. [Treatment options in non-Hodgkin lymphomas].
Tilly H
Rev Prat; 2010 Jan; 60(1):69-74. PubMed ID: 20222315
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic approaches to non-Hodgkin's lymphomas.
Lambert JF; Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
[No Abstract] [Full Text] [Related]
10. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
[TBL] [Abstract][Full Text] [Related]
11. Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
Kiewe P; Thiel E
Ann Hematol; 2011 Jan; 90(1):109-10. PubMed ID: 20387065
[No Abstract] [Full Text] [Related]
12. Primary large B-cell lymphoma of the bone marrow.
Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
[No Abstract] [Full Text] [Related]
13. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Spina M; Simonelli C; Tirelli U
J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261
[No Abstract] [Full Text] [Related]
14. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Alliot C
J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
[No Abstract] [Full Text] [Related]
15. Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old.
Italiano A; Jardin F; Peyrade F; Saudes L; Tilly H; Thyss A
Haematologica; 2005 Sep; 90(9):1281-3. PubMed ID: 16154857
[TBL] [Abstract][Full Text] [Related]
16. Richter's syndrome: a novel presentation.
Smyth EF; Bartlett RJ; Shields ML; White TJ; Wengraf C
Ulster Med J; 2003 May; 72(1):58-60. PubMed ID: 12868708
[No Abstract] [Full Text] [Related]
17. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma.
Shabbat S; Aharoni J; Sarid L; Ben-Harush M; Kapelushnik J
Pediatr Blood Cancer; 2009 May; 52(5):664-6. PubMed ID: 19142990
[TBL] [Abstract][Full Text] [Related]
18. Aggressive primary thyroid non Hodgkin's lymphoma with pregnancy.
Soliman KB; Abbas MM; Seksaka MA; Wafa S; Balah AS
Saudi Med J; 2007 Apr; 28(4):634-6. PubMed ID: 17457494
[TBL] [Abstract][Full Text] [Related]
19. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
[No Abstract] [Full Text] [Related]
20. A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma.
Pangalis GA; Vassilakopoulos TP; Michalis E; Roussou P; Vrakidou E; Repousis P; Angelopoulou MK; Siakantaris MP; Korantzis J; Symeonidis A; Grigorakis V; Stefanoudakis E; Stamatellou M; Bourantas KL; Kalmantis T; Christopoulos G; Kokkinis G; Mihalakeas I; Papayiannis A;
Leuk Lymphoma; 2003 Apr; 44(4):635-44. PubMed ID: 12769340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]